Therapeutic implication of autophagy in neurodegenerative diseases

키워드

참고문헌 (104)

1. Mizushima N, "Autophagy fights disease through cellular selfdigestion", Nature, 451, pp.1069~1075 (2008)
2. Kotoulas OB, "Glycogen autophagy in glucose homeostasis", Pathol Res Pract, 202, pp.631~638 (2006)
3. Singh R, "Autophagy regulates lipid metabolism", Nature, 458, pp.1131~1135 (2009)
4. Rubinsztein DC, "Autophagy and aging", Cell, 146, pp.682~695 (2011)
5. Toth ML, "Longevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans", Autophagy, 4, pp.330~338 (2008)
6. Simonsen A, "Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila", Autophagy, 4, pp.176~184 (2008)
7. Meng Q, "Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)", NF-kappaB pathway, 2011, pp.286, 32324~32332
8. Yang L, "Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance", Cell Metab, 11, pp.467~478 (2010)
9. Jung HS, "Role of autophagy in diabetes and mitochondria", Ann N Y Acad Sci, 1201, pp.79~83 (2010)
10. Komatsu M, "Loss of autophagy in the central nervous system causes neurodegeneration in mice", Nature, 441, pp.880~884 (2006)
11. Spilman P, "Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease", PLoS One, 5, pp.e9979~ (2010)
12. Rodriguez-Navarro JA, "Trehalose ameliorates dopaminergic and tau pathology in parkin deleted", tau overexpressing mice through autophagy activation, 2010, pp.39, 423~438
13. Pan T, "The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease", Brain, 131, pp.1969~1978 (2008)
14. Ravikumar B, "Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease", Nat Genet, 36, pp.585~595 (2004)
15. Hara T, "Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice", Nature, 441, pp.885~889 (2006)
16. Hernandez D, "Regulation of presynaptic neurotransmission by macroautophagy", Neuron, 74, pp.277~284 (2012)
17. Komatsu M, "Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration", Proc Natl Acad Sci U S A, 104, pp.14489~14494 (2007)
18. Nixon RA, "The role of autophagy in neurodegenerative disease", Nat Med, 19, pp.983~997 (2013)
19. Hamasaki M, "Autophagosomes form at ER- mitochondria contact sites", Nature, 495, pp.389~393 (2013)
20. Ge L, "Phosphatidylinositol 3-kinase and COPII generate LC3 lipidation vesicles from the ER-Golgi intermediate compartment", Elife, 3, pp.e04135~ (2014)
21. Moreau K, "Autophagosome precursor maturation requires homotypic fusion", Cell, 146, pp.303~317 (2011)
22. Pozueta J, "Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice", Nat Commun, 4, pp.1939~ (2013)
23. Ohashi Y, "Membrane delivery to the yeast autophagosome from the Golgi-endosomal system", Mol Biol Cell, 21, pp.3998~4008 (2010)
24. Shpilka T, "Lipid droplets and their component triglycerides and steryl esters regulate autophagosome biogenesis", EMBO J, 34, pp.2117~2131 (2015)
25. Rubinsztein DC, "Mechanisms of autophagosome biogenesis", Curr Biol, 22, pp.R29~R34 (2012)
26. Ohsumi Y, "Historical landmarks of autophagy research", Cell Res, 24, pp.9~23 (2014)
27. Pankiv S, "p62", SQSTM1 binds directly to Atg8, J Biol Chem, pp.2007, 282[DOI]
28. Thurston TLM, "The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitincoated bacteria", Nat Immunol, 10, pp.1215~1221 (2009)
29. Rabinowitz JD, "Autophagy and metabolism", Science, 330, pp.1344~1348 (2010)
30. Geisler S, "PINK1", Parkin-mediated mitophagy is dependent on VDAC1 and p62, Nat Cell Biol, pp.2010, 12[DOI]
31. Kim PK, "Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes", Proc Natl Acad Sci U S A, 105, pp.20567~20574 (2008)
32. Bernales S, "ER-phagy : selective autophagy of the endoplasmic reticulum", Autophagy, 3, pp.285~287 (2007)
33. Kirkin V, "A role for NBR1 in autophagosomal degradation of ubiquitinated substrates", Mol Cell, 33, pp.505~516 (2009)
34. Giacomelli C, "Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases", Biochem Pharmacol, 131, pp.1~15 (2017)
35. Berger Z, "Rapamycin alleviates toxicity of different aggregateprone proteins", Hum Mol Genet, 15, pp.433~442 (2006)
36. Spencer B, "Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson’s and Lewy body diseases", J Neurosci, 29, pp.13578~13588 (2009)
37. De Strooper B, "The Cellular Phase of Alzheimer’s Disease", Cell, 164, pp.603~615 (2016)
38. Zare-Shahabadi A, "Autophagy in Alzheimer’s disease", Rev Neurosci, 26, pp.385~395 (2015)
39. Iqbal K, "Tau and neurodegenerative disease: the story so far", Nat Rev Neurol, 12, pp.15~27 (2016)
40. Lin LF, "Combination of Abeta clearance and neurotrophic factors as a potential treatment for Alzheimer’s disease", Neurosci Bull, 29, pp.111~120 (2013)
41. Boland B, "Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease", J Neurosci, 28, pp.6926~6937 (2008)
42. Nilsson P, "Abeta secretion and plaque formation depend on autophagy", Cell Rep, 5, pp.61~69 (2013)
43. Xue Z, "Beta-asarone attenuates amyloid beta-induced autophagy via Akt", mTOR pathway in PC12 cells, 2014, pp.741, 195~204
44. Wolfe DM, "Autophagy failure in Alzheimer’s disease and the role of defective lysosomal acidification", Eur J Neurosci, 37, pp.1949~1961 (2013)
45. Tan CC, "Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy", Neurobiol Aging, 35, pp.941~957 (2014)
46. Jaber N, "Class III PI3K Vps34: essential roles in autophagy, endocytosis, and heart and liver function", Ann N Y Acad Sci, 1280, pp.48~51 (2013)
47. Martinez-Vicente M, "Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation", Semin Cell Dev Biol, 40, pp.15~26 (2015)
48. Eketjall S, "AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice", J Neurosci, 33, pp.10075~10084 (2013)
49. Marwarha G, "Leptin attenuates BACE1 expression and amyloid-beta genesis via the activation of SIRT1 signaling pathway", Biochim Biophys Acta, 1842, pp.1587~1595 (2014)
50. Murakami K, "Pharmacological properties of a novel and potent gamma-secretase modulator as a therapeutic option for the treatment of Alzheimer’s disease", Brain Res, 1633, pp.73~86 (2016)
51. Geldenhuys WJ, "Pharmacotherapy of Alzheimer’s disease: current and future trends", Expert Rev Neurother, 15, pp.3~5 (2015)
52. Gauthier S, "Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer’s disease", Alzheimers Dement, 9, pp.326~331 (2013)
53. Ismaili L, "Multitarget compounds bearing tacrine-and donepezillike structural and functional motifs for the potential treatment of Alzheimer’s disease", Prog Neurobiol, 151, pp.4~34 (2017)
54. Li L, "Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-beta pathology in a mouse model of Alzheimer’s disease", Curr Alzheimer Res, 10, pp.433~441 (2013)
55. Majumder S, "Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits", PLoS One, 6, pp.e25416~ (2011)
56. Zhang X, "Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer’s disease transgenic mouse model", J Alzheimers Dis, 24, pp.739~749 (2011)
57. Steele JW, "Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer’s mouse model", Mol Psychiatry, 18, pp.889~897 (2013)
58. Schaeffer V, "Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy", Brain, 135, pp.2169~2177 (2012)
59. Ozcelik S, "Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice", PLoS One, 8, pp.e62459~ (2013)
60. Shimada K, "Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: implications of autophagy promotion", Neurobiol Dis, 46, pp.101~108 (2012)
61. Lees AJ, "Parkinson’s disease", Lancet (London, England), 373, pp.2055~2066
62. Sveinbjornsdottir S, "The clinical symptoms of Parkinson’s disease", J Neurochem, 139, pp.318~324 (2016)
63. Martin I, "Recent advances in the genetics of Parkinson’s disease", Annu Rev Genomics Hum Genet, 12, pp.301~325 (2011)
64. Goedert M, "100 years of Lewy pathology", Nat Rev Neurol, 9, pp.13~24 (2013)
65. Winslow AR, "alpha-Synuclein impairs macroautophagy: implications for Parkinson’s disease", J Cell Biol, 190, pp.1023~1037 (2010)
66. Williams A, "Novel targets for Huntington’s disease in an mTORindependent autophagy pathway", Nat Chem Biol, 4, pp.295~305 (2008)
67. Decressac M, "TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity", Proc Natl Acad Sci U S A, 110, pp.E1817~E1826 (2013)
68. Kahle PJ, "alpha-Synucleinopathy models and human neuropathology: similarities and differences", Acta Neuropathol, 115, pp.87~95 (2008)
69. Rubinsztein DC, "Autophagy modulation as a potential therapeutic target for diverse diseases", Nat Rev Drug Discov, 11, pp.709~730 (2012)
70. Maiese K, "mTOR : on target for novel therapeutic strategies in the nervous system", Trends Mol Med, 19, pp.51~60 (2013)
71. Webb JL, "Alpha-Synuclein is degraded by both autophagy and the proteasome", J Biol Chem, 278, pp.25009~25013 (2003)
72. Crews L, "Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy", PLoS One, 5, pp.e9313~ (2010)
73. Pan T, "Rapamycin protects against rotenone-induced apoptosis through autophagy induction", Neuroscience, 164, pp.541~551 (2009)
74. Malagelada C, "Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson’s disease", J Neurosci, 30, pp.1166~1175 (2010)
75. Bai X, "Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy", Pathobiol Aging Age Relat Dis, 5, pp.28743~ (2015)
76. Tain LS, "Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss", Nat Neurosci, 12, pp.1129~1135 (2009)
77. Bove J, "Fighting neurodegeneration with rapamycin: mechanistic insights", Nat Rev Neurosci, 12, pp.437~452 (2011)
78. Forlenza O V, "Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders", ACS Chem Neurosci, 5, pp.443~560 (2014)
79. Sarkar S, "Lithium induces autophagy by inhibiting inositol monophosphatase", J Cell Biol, 170, pp.1101~1111 (2005)
80. Hou L, "Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement", BMC Neurosci, 16, pp.82~ (2015)
81. Chao TK, "Risk factors for the onset and progression of Huntington disease", Neurotoxicology, 2130, pp.21~ (2017)
82. Fan HC, "Polyglutamine (PolyQ) diseases: genetics to treatments", Cell Transplant, 23, pp.441~458 (2014)
83. Jiang W, "Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model", PLoS One, 10, pp.e0134142~ (2015)
84. Wu AG, "Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant alpha-synuclein and huntingtin in PC-12 cells", Int J Mol Sci, 14, pp.22618~22641 (2013)
85. Sun YM, "Spinocerebellar ataxia: relationship between phenotype and genotype - a review", Clin Genet, 90, pp.305~314 (2016)
86. Menzies FM, "Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3", Brain, 133, pp.93~104 (2010)
87. Lin CH, "Novel Lactulose and Melibiose Targeting Autophagy to Reduce PolyQ Aggregation in Cell Models of Spinocerebellar Ataxia 3", CNS Neurol Disord Drug Targets, 15, pp.351~ (2016)
88. Zarei S, "A comprehensive review of amyotrophic lateral sclerosis", Surg Neurol Int, 6, pp.171~ (2015)
89. Morimoto N, "Increased autophagy in transgenic mice with a G93A mutant SOD1 gene", Brain Res, 1167, pp.112~117 (2007)
90. Gal J, "Sequestosome 1", p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism, 2009, pp.111, 1062~1073
91. Castillo K, "Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons", Autophagy, 9, pp.1308~1320 (2013)
92. Frake RA, "Autophagy and neurodegeneration", J Clin Invest, 125, pp.65~74 (2015)
93. Moreau K, "PICALM modulates autophagy activity and tau accumulation", Nat Commun, 5, pp.4998~ (2014)
94. Benjamin D, "Rapamycin passes the torch: a new generation of mTOR inhibitors", Nat Rev Drug Discov, 10, pp.868~880 (2011)
95. Choi H, "Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Abeta-induced impaired axonal transport", Mol Neurodegener, 12, pp.23~ (2017)
96. Cha MY, "Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Abeta Deposition in a Mouse Model of Alzheimer’s Disease", Stem Cells Transl Med, 6, pp.293~305 (2017)
97. Son SM, "Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease", Autophagy, 12, pp.784~800 (2016)
98. Son SM, "Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway", Mol Neurodegener, 10, pp.56~ (2015)
99. Huang L, "Oxoisoaporphine alkaloid derivative 8-1 reduces Abeta1- 42 secretion and toxicity in human cell and Caenorhabditis elegans models of Alzheimer’s disease", Neurochem Int, 108, pp.157~168 (2017)
100. Huang M, "Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP", tau, Exp Gerontol, pp.2017, 91[DOI]
101. Jiang TF, "Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson’s disease through the downregulation of mTOR", p70S6K signaling and the recovery of macroautophagy, 2013, pp.8, 356~369
102. Rahman MA, "Oxyresveratrol activates parallel apoptotic and autophagic cell death pathways in neuroblastoma cells", Biochim Biophys Acta, 1861, pp.23~36 (2017)
103. Rahman MA, "18alpha-Glycyrrhetinic acid lethality for neuroblastoma cells via de-regulating the Beclin-1", Bcl-2 complex and inducing apoptosis, 2016, pp.117, 97~112
104. Bernard A, "A large-scale analysis of autophagy-related gene expression identifies new regulators of autophagy", Autophagy, 11, pp.2114~2122 (2015)

관련 논문AI추천